Key Stats for Xylem Stock
- Past-Week Performance: -2.7%
- 52-Week Range: $100.5 to $154.3
- Current Price: $119.9
What Happened?
Water infrastructure company Xylem (XYL) posted record FY 2025 adjusted EBITDA of $2.0 billion and adjusted EPS of $5.08, yet the stock has shed roughly 14% since its February 10 earnings close to $119.88.
Xylem’s Q4 adjusted EPS of $1.42 beat the $1.41 consensus while revenue of $2.4 billion cleared the $2.374 billion estimate, but FY 2026 revenue guidance of $9.1 billion to $9.2 billion landed well below the $9.33 billion Wall Street expected.
The adjusted EBITDA margin expanded 160 basis points to 22.2% for the full year, already ahead of the 23% target Xylem set at its May 2024 Investor Day for 2027, validating a faster-than-expected operational turnaround.
Chief Executive Matthew Pine stated on the Q4 2025 earnings call that “2026 will be the peak of purposeful walkaways from lower-quality revenue,” directly tying the soft top-line guide to a deliberate 80/20 simplification program that management expects to generate $80 million to $120 million in annual net savings beginning in 2026.
With the international metering divestiture closing at the end of Q1 2026, M&A capital exceeding $250 million already in process for H1 2026, and Xylem Vue digital revenue targeting 30%-plus growth, the company’s transition from margin recovery to earnings-quality compounder is progressing a full year ahead of the framework it laid out in 2024.
Wall Street’s Take on XYL Stock
The deliberate revenue sacrifice embedded in Xylem’s 80/20 simplification program, which management flagged as a 2% top-line headwind in 2026, is directly responsible for the post-earnings selloff that dragged the stock from $140.19 to $119.88.

The market is pricing Xylem as a decelerating industrial, yet the 80/20 simplification program stripping low-margin revenue is simultaneously expanding EBITDA margins from 22.2% in 2025 toward 24.0% by 2027, driving normalized EPS from $5.08 to a consensus $6.09 over the same window.

Fifteen of 23 covering analysts rate XYL a buy or outperform, with a mean price target of $158.41 that implies 32.1% upside from current levels, reflecting confidence that margin expansion will overwhelm the transient revenue headwind.
The $63-wide spread between the $123.00 low target and $186.00 high target maps directly onto the 80/20 execution risk: bulls reward successful simplification with a re-rating, bears price in prolonged top-line pressure if walkaway revenue exceeds the guided 2% drag.
What Does the Valuation Model Say?

TIKR’s model targets $183.01, pricing in a mid-case revenue CAGR of 4.5% and net income margins expanding to 15.8%, both conservative relative to the operating leverage already visible in Xylem’s 160-basis-point EBITDA margin gain in 2025.
The market is treating a guided 1% to 3% revenue growth year as structural impairment, while EBITDA margins are tracking a full year ahead of the 23% target Xylem set for 2027.
The 80/20 restructuring program, targeting $80 million to $120 million in annual net savings from 2026, and Xylem Vue’s 30%-plus growth trajectory together justify TIKR’s $183.01 target.
Management’s own framing that 2026 is “the peak of purposeful walkaways” signals the top-line drag is finite and the earnings quality inflection is structural, not cyclical.
A deterioration in MCS order conversion, specifically if the 5 to 10 smart metering projects currently tracking for H1 2026 push further out, breaks TIKR’s 4.5% revenue CAGR assumption and compresses the path to $183.01.
Q1 2026 earnings are the first confirmation gate: watch MCS sequential revenue direction and whether EBITDA margin holds above 20.5%, the floor management guided, as proof the simplification is delivering margin without volume.
Should You Invest in Xylem Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up XYL stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Xylem Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze XYL stock on TIKR for Free →